These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 26101204)
1. Glutamatergic Mechanisms Associated with Seizures and Epilepsy. Barker-Haliski M; White HS Cold Spring Harb Perspect Med; 2015 Jun; 5(8):a022863. PubMed ID: 26101204 [TBL] [Abstract][Full Text] [Related]
2. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Peña F; Tapia R Neuroscience; 2000; 101(3):547-61. PubMed ID: 11113304 [TBL] [Abstract][Full Text] [Related]
3. Research advances in basic mechanisms of seizures and antiepileptic drug action. Lasoń W; Chlebicka M; Rejdak K Pharmacol Rep; 2013; 65(4):787-801. PubMed ID: 24145073 [TBL] [Abstract][Full Text] [Related]
4. Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex. Világi I; Dobó E; Borbély S; Czégé D; Molnár E; Mihály A Exp Neurol; 2009 Sep; 219(1):136-45. PubMed ID: 19445932 [TBL] [Abstract][Full Text] [Related]
5. Extrasynaptic GABA and glutamate receptors in epilepsy. Sierra-Paredes G; Sierra-Marcuño G CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):288-300. PubMed ID: 17691986 [TBL] [Abstract][Full Text] [Related]
6. Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy. Zaitsev AV; Smolensky IV; Jorratt P; Ovsepian SV CNS Drugs; 2020 Nov; 34(11):1089-1103. PubMed ID: 32926322 [TBL] [Abstract][Full Text] [Related]
7. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. Lange F; Hörnschemeyer J; Kirschstein T Cells; 2021 May; 10(5):. PubMed ID: 34067762 [TBL] [Abstract][Full Text] [Related]
8. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. Levite M J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016 [TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats. Zaitsev AV; Malkin SL; Postnikova TY; Smolensky IV; Zubareva OE; Romanova IV; Zakharova MV; Karyakin VB; Zavyalov V Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766528 [TBL] [Abstract][Full Text] [Related]
10. Glutamate receptors in epilepsy. Chapman AG Prog Brain Res; 1998; 116():371-83. PubMed ID: 9932389 [TBL] [Abstract][Full Text] [Related]
11. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development. Green JL; Dos Santos WF; Fontana ACK Biochem Pharmacol; 2021 Nov; 193():114786. PubMed ID: 34571003 [TBL] [Abstract][Full Text] [Related]
12. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Bazan NG; Tu B; Rodriguez de Turco EB Prog Brain Res; 2002; 135():175-85. PubMed ID: 12143339 [TBL] [Abstract][Full Text] [Related]
13. Beyond the role of glutamate as a neurotransmitter. Nedergaard M; Takano T; Hansen AJ Nat Rev Neurosci; 2002 Sep; 3(9):748-55. PubMed ID: 12209123 [TBL] [Abstract][Full Text] [Related]
14. Effects of 3-aminoglutarate, a "silent" false transmitter for glutamate neurons, on synaptic transmission and epileptiform activity. Wu Z; Foster AC; Staubli U; Wu X; Sun C; Tang X; Li YX; Chen G Neuropharmacology; 2015 Oct; 97():95-103. PubMed ID: 26002626 [TBL] [Abstract][Full Text] [Related]
15. Aspects of cAMP Signaling in Epileptogenesis and Seizures and Its Potential as Drug Target. Mertz C; Krarup S; Jensen CD; Lindholm SEH; Kjær C; Pinborg LH; Bak LK Neurochem Res; 2020 Jun; 45(6):1247-1255. PubMed ID: 31414342 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone's antiepileptic action in FeCl3-induced epileptogenesis involves upregulation of glutamate transporters. Mishra M; Singh R; Mukherjee S; Sharma D Epilepsy Res; 2013 Sep; 106(1-2):83-91. PubMed ID: 23891458 [TBL] [Abstract][Full Text] [Related]
17. The role of glial membrane ion channels in seizures and epileptogenesis. D'Ambrosio R Pharmacol Ther; 2004 Aug; 103(2):95-108. PubMed ID: 15369678 [TBL] [Abstract][Full Text] [Related]
18. Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. de Oliveira DL; Horn JF; Rodrigues JM; Frizzo ME; Moriguchi E; Souza DO; Wofchuk S Brain Res; 2004 Aug; 1018(1):48-54. PubMed ID: 15262204 [TBL] [Abstract][Full Text] [Related]
19. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Casillas-Espinosa PM; Powell KL; O'Brien TJ Epilepsia; 2012 Dec; 53 Suppl 9():41-58. PubMed ID: 23216578 [TBL] [Abstract][Full Text] [Related]